详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Wei Xu[1] * ; Yongping Song[2] ; Zengjun Li[3] ; Shenmiao Yang[4] ; Lihong Liu[5]

; Yu Hu[6] ; Wei Zhang[7] ; Jianfeng Zho[8] ; Sujun Gao[9] ; Kaiyang Ding[10] ; Huilai Zhang[11] ; Zunmin Zhu[12] ; Shunqing Wang[13] ; Bing Xu[14] ; Jianda Hu[15] ; Ting Liu[16] ; Chunyan Ji[17] ; Zhongjun Xia[18] ; Yan Li[19] ; Xin Wang[20] ; Zhixin Xu[21] ; Renbin Zhao[22] ; Bin Zhang[22] ; Alan Zhu[21] ; Jianyong Li[1] ;

机构： [1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China [2]Hematology, Henan Cancer Hospital, Zhengzhou, CHN [3]Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China [4]Hematology, Peking University People's Hospital, Beijing, CHN [5]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [6]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [7]Peking Union Medical College Hospital, Beijing, CHN [8]Department of Hematology, Tongji Hospital Huazhong University of Science and Technology, Wuhan, China [9]Department of Hematology, The First Hospital, Jilin University, Changchun, China [10]Anhui Provincial Cancer Hospital, Hefei, China [11]Tianjin Medical University Cancer Institute & Hospital, Tianjin, China [12]Hematology, Henan Provincial People's Hospital, Zhengzhou, CHN [13]Guangzhou First People's Hospital, Guangzhou, CHN [14]Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China [15]Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Union Hospital, Fujian Institute of Hematology, Fuzhou, China [16]Department of Hematology, West China Hospital Sichuan University, Chengdu, China [17]Department of Hematology, Qilu Hospital of Shandong University, Jinan, China [18]oncology, cancer center, Sun Yat-sen University, Guangzhou, CHN [19]Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang City, China [20]Hematology, School of Medicine, Shandong University, Jinan, China [21]Beijing InnoCare Pharma Tech Co., Ltd, Beijing, China [22]Beijing InnoCare Pharma Tech Co., Ltd., Beijing, China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2019]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

第一作者：

第一作者机构： [1]Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

文献详情